Literature DB >> 31933986

Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.

Qiong Wu1,2, Jingping Wang1,2, Yuanyuan Liu1,2, Xiaomeng Gong1,2.   

Abstract

Triple-negative breast cancer (TNBC) is associated with epithelial-mesenchymal transition (EMT) and the phenotype of breast cancer stem cells (CSCs). Vasculogenic mimicry (VM) is a novel pattern of tumor blood supply and associated with aggression and metastasis of TNBC. Previous studies have shown that both CSCs and EMT are associated with VM, although the underlying mechanism is yet unclear. The present study aimed to analyze the immunohistochemical (IHC) expression of CSC marker, epithelial cell adhesion molecule (EpCAM), EMT-related markers, including transcription factors (TFs) (Slug, Twist1, and ZEB1), and EMT markers (E-cadherin and vimentin) in 137 TNBC. The expression of these markers was correlated to the clinicopathological features and VM channels of the tumors, including patient overall survival (OS) and disease-free survival (DFS). Furthermore, the expression of EpCAM and EMT-related markers showed a positive correlation with distant metastasis and lymph node metastasis (P < 0.05). A significant association was noted between VM and histological grade (P = 0.007). Moreover, VM showed a significant positive correlation with EpCAM, EMT-associated TFs, and VE-cadherin expression in TNBC. Furthermore, binary logistic analysis showed that VM expression was significantly correlated with lymph node metastasis and distant metastasis (P < 0.05). In survival analysis, the overexpression of EpCAM and ZEB1 predicted a poor prognosis with respect to OS and DFS. In addition, the presence of VM was significantly associated with poor OS and DFS. Multivariate Cox regression analysis revealed that VM expression is an independent prognostic factor for TNBC patients. In summary, VM was confirmed as a potential biomarker for TNBC associated with poor clinical outcomes and tumor metastasis. This study also suggested that EpCAM protein might be involved in VM formation by EMT in TNBC. IJCEP
Copyright © 2019.

Entities:  

Keywords:  EMT; EpCAM; TNBC; VM; metastasis; prognosis

Year:  2019        PMID: 31933986

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  11 in total

1.  Overexpression of heat shock protein 70 inhibits epithelial-mesenchymal transition and cell migration induced by transforming growth factor-β in A549 cells.

Authors:  Fengxian Shi; Mingze Ma; Ruonan Zhai; Yanan Ren; Ke Li; Hang Wang; Chunyan Xu; Xiaowen Huang; Na Wang; Fang Zhou; Wu Yao
Journal:  Cell Stress Chaperones       Date:  2021-02-17       Impact factor: 3.667

Review 2.  Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.

Authors:  Stefania Cocco; Michela Piezzo; Alessandra Calabrese; Daniela Cianniello; Roberta Caputo; Vincenzo Di Lauro; Giuseppina Fusco; Germira di Gioia; Marina Licenziato; Michelino De Laurentiis
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

3.  Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.

Authors:  Anzhelika Vorobyeva; Ekaterina Bezverkhniaia; Elena Konovalova; Alexey Schulga; Javad Garousi; Olga Vorontsova; Ayman Abouzayed; Anna Orlova; Sergey Deyev; Vladimir Tolmachev
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 4.  Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?

Authors:  Marta Marqués; Maria Alba Sorolla; Izaskun Urdanibia; Eva Parisi; Iván Hidalgo; Serafín Morales; Antonieta Salud; Anabel Sorolla
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

5.  Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.

Authors:  Seung-Uon Shin; Hyun-Mi Cho; Rathin Das; Hava Gil-Henn; Sundaram Ramakrishnan; Ahmed Al Bayati; Stephen F Carroll; Yu Zhang; Ankita P Sankar; Christian Elledge; Augustin Pimentel; Marzenna Blonska; Joseph D Rosenblatt
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

6.  TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells.

Authors:  M Wu; X Sun; T Wang; M Zhang; P Li
Journal:  Clin Transl Oncol       Date:  2021-07-03       Impact factor: 3.405

7.  CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.

Authors:  Mingxin Wen; Hui Ren; Shouqiang Zhang; Tao Li; Jiefeng Zhang; Peng Ren
Journal:  Cell Death Dis       Date:  2021-06-25       Impact factor: 8.469

Review 8.  Targeting Autophagy in Breast Cancer.

Authors:  Stefania Cocco; Alessandra Leone; Michela Piezzo; Roberta Caputo; Vincenzo Di Lauro; Francesca Di Rella; Giuseppina Fusco; Monica Capozzi; Germira di Gioia; Alfredo Budillon; Michelino De Laurentiis
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

9.  Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo.

Authors:  Patrícia de Faria Lainetti; Andressa Brandi; Antonio Fernando Leis Filho; Maria Carolina Mangini Prado; Priscila Emiko Kobayashi; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Front Vet Sci       Date:  2020-10-27

Review 10.  Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.

Authors:  Taylor C Brown; Narendra V Sankpal; William E Gillanders
Journal:  Biomolecules       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.